Aesthetic Device Clearance Tracker: FDA-Cleared Energy Devices

The FDA clears aesthetic devices via two pathways: 510(k) (substantial equivalence to a predicate device; faster, lower bar) and PMA (Premarket Approval; rigorous clinical data required for novel mechanisms). A 510(k) clearance means the device is substantially equivalent to an existing cleared device in intended use and technological characteristics—not that it's equally effective, only that it's safe and effective for the claimed indication. A PMA requires clinical trials and is reserved for higher-risk or novel-mechanism devices. Reps often conflate "cleared" with "approved for any use"—it's not. Each clearance specifies an indication (e.g., "temporary improvement of moderate to severe glabellar lines"). Using a device outside its cleared indication is off-label and exposes you to liability, FDA warning letters, and loss of reimbursement. Always request the 510(k) summary or PMA approval letter from the vendor and cross-check the indication against your intended use.

RF devices use electromagnetic energy to heat tissue and induce collagen remodeling. Thermage (Solta Medical, now part of Staar Surgical) was cleared via 510(k) for "non-invasive skin tightening" and is widely used off-label for body contouring and cellulite. Inmode's Morpheus8 (fractional microneedling-RF) is cleared for "skin resurfacing and wrinkle reduction" and has become the workhorse for lower-face and body texture. Inmode's BodyTite (invasive RF) is cleared for "liposuction and skin tightening" and requires surgical incisions. Cutera's Thermage FLX is the latest-generation RF platform, cleared for non-invasive skin tightening. Verify the specific cleared indication: some RF devices are cleared only for face, others for body; some for wrinkles, others for laxity. Off-label use (e.g., using a face-only device on the neck) is common but undocumented and creates liability if complications arise. Request the 510(k) summary to confirm the cleared body area and clinical endpoint.

Laser devices are typically cleared via 510(k) for specific wavelengths and indications. Cutera's Coolglide (Nd:YAG) is cleared for hair removal and vascular lesions. Cutera's Excel V (532 nm KTP + 1064 nm Nd:YAG) is cleared for vascular and pigmented lesions. Lumenis' ResurFX (fractional CO2) is cleared for skin resurfacing and wrinkle reduction. Cynosure's PicoWay (picosecond laser) is cleared for tattoo removal and pigmented lesions. Each laser has a defined wavelength, pulse duration, and cleared indication. Reps sometimes claim a device can treat "all skin types" or "any pigmentation"—verify against the 510(k) summary. Fractional lasers (which create microscopic treatment zones) have different safety profiles than ablative lasers (which remove the entire epidermis); the FDA distinguishes these in clearances. Combination devices (e.g., RF + laser) may have separate clearances for each modality—request documentation for each.

Ultherapy (Ulthera, now Merz) uses focused ultrasound energy (HIFU) and is cleared via PMA for "non-invasive eyebrow lift" and "non-invasive skin tightening of the décolletage." HIFU devices are high-risk because they deliver energy deep into tissue; the PMA pathway reflects that. Sofwave (Sofwave Medical) uses synchronous ultrasound pulses and is cleared for "non-invasive skin tightening and wrinkle reduction." Exilis (BTL Aesthetics) combines RF and ultrasound and is cleared for "non-invasive skin tightening." Biostimulator injectables (PLLA, CaHA) are cleared as dermal fillers with specific indications; they are not energy devices but are often bundled with RF or ultrasound in treatment protocols. Verify that ultrasound devices are cleared for the specific body area you intend to treat—clearances often exclude the eye area or specify depth limitations.

The FDA's 510(k) database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm) is publicly searchable by device name, company, or predicate device. Search for your device and download the 510(k) summary; it will list the intended use, technological characteristics, and performance data. For PMA devices, search the FDA's PMA database (accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma.cfm). When a rep pitches a device, request the 510(k) summary or PMA approval letter in writing—do not accept verbal assurances. Cross-reference the cleared indication against your intended use. If you plan to use the device off-label (common in aesthetics), document that decision and ensure your liability insurance covers off-label use. State medical boards increasingly scrutinize off-label device use; some states require written informed consent for off-label indications. Before signing a device lease or purchase agreement, verify clearance status independently—vendors sometimes misrepresent or omit limitations.

Watch for these claims: "FDA-approved for any skin type" (lasers have skin-type limitations based on chromophore absorption); "cleared for all body areas" (most devices have face-only or face + neck clearances); "works like [competitor device]" without citing the same 510(k) predicate (suggests different mechanism, may not be cleared for your use); "cleared for cellulite" (few devices have explicit cellulite clearance; most are used off-label); and "cleared for fat reduction" without surgical incision (non-invasive RF is cleared for skin tightening, not fat removal). If a rep cannot produce the 510(k) summary or PMA letter within 48 hours, escalate to the manufacturer's regulatory affairs team. Misrepresentation of FDA clearance is a violation of FDA regulations and can result in warning letters to the practice. Document all clearance verification in your device file; if you are audited by your state board or FDA, you will need to prove you used devices within their cleared indications.